Featuring perspectives from Dr Dana M Chase, Ms Sarah Karpen, Dr J Alejandro Rauh-Hain and Ms Jaclyn Shaver, moderated by Dr Chase, including the following topics:
Introduction: Biology of Endometrial Cancer (EC)(0:00)
First-Line Therapy for Advanced or Recurrent EC (14:15)
Potential Benefits of PARP Inhibition Combined with Immunotherapy in Advanced EC (35:13)
Role of Lenvatinib/Pembrolizumab in the Management of Progressive Advanced EC (57:48)
Other Nursing Considerations in the Care of Patients with Advanced EC (1:17:28)
Podden och tillhörande omslagsbild på den här sidan tillhör
Dr Neil Love. Innehållet i podden är skapat av Dr Neil Love och inte av,
eller tillsammans med, Poddtoppen.